Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD

Medical Science Monitor

Volumn 15, Issue 10, 2009, Pages

  Skyba, Peter ^a   Kluchova, Zuzana ^a   Joppa, Pavol ^a   Petrasova, Darina ^b   Tkacova, Ruzena ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Adult nutrition; Bronchial obstruction; C reactive protein; COPD exacerbation; Hyperinflation

Indexed keywords

C REACTIVE PROTEIN; CATALASE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BODY MASS; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; INFLAMMATION; INSPIRATORY CAPACITY; LIPID PEROXIDATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RESIDUAL VOLUME; TOTAL LUNG CAPACITY;

AGED; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 70349974714     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schols AMWJ, Slangen J, Volovics L, Wouters EFM: Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998; 157: 1791-1797 (Pubitemid 28311260)
2. Schols AM: Pulmonary cachexia. Int J Cardiol, 2002; 85: 275-280
3. Agusti AG, Noguera A, Sauleda J et al: Systemic effects of chronic obstructive pulmonary disease. Eur Respir J, 2003; 21: 347-360 (Pubitemid 36204553)
4. Landbo C, Prescott E, Lange P et al: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999; 160: 1856-1861 (Pubitemid 30004687)
5. Chailleux E, Laaban JP, Veale D: Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy. Chest, 2003; 123: 1460-1466
6. Schols AMWJ, Broekhuizen R, Weling-Scheepers CA et al: Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr, 2005; 82: 53-59 (Pubitemid 41716377)
7. Celli BR, Cote CG, Marin JM et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004; 350: 1005-1012 (Pubitemid 38269277)
8. Vestbo J, Prescott E, Almdal T et al: Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample. Am J Respir Crit Care Med, 2006; 173: 79-83
9. Hallin R, Gudmundsson G, Suppli et al: Nutritional status and longterm mortality in hospitalized patients with chronic obstructive pulmonary disease (COPD). Respir Med, 2007; 101: 1954-1960
10. Hallin R, Koivisto-Hursti UK, Lindberg E, Janson C: Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med, 2006; 100: 561-567
11. Engelen MPKJ, Schols AMWJ, Lamers RJS, Wouters EFM: Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr, 1999; 18: 275-280 (Pubitemid 29527736)
12. Budweiser S, Heinemann F, Meyer K et al: Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation. Respir Care, 2006; 51: 126-132 (Pubitemid 46888410)
13. Ischaki E, Papatheodorou G, Gaki E et al: Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest, 2007; 132: 164-169 (Pubitemid 47068217)
14. de Torres JP, Cordoba-Lanus E, Lopez-Aguillar C et al: C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J, 2006; 27: 902-907 (Pubitemid 44911101)
15. Man SF, Connett JE, Anthonisen NR et al: C-reactive protein and mortality in mild to moderate obstructive pulmonary disease. Thorax, 2006; 61: 849-853 (Pubitemid 44570304)
16. Pinto-Plata VM, Mullerova H, Toso JF et al: C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax, 2006; 61: 23-28 (Pubitemid 43106973)
17. Karadag F, Kirdar S, Karul AB, Ceylan E: The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med, 2008; 19: 104-108
18. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM: Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax, 2006; 61: 17-22 (Pubitemid 43106972)
19. Wedzicha JA, Seemungal TAR: COPD exacerbations: defining their cause and prevention. Lancet, 2007; 370: 786-796
20. Drost EM, Skwarski KM, Sauleda KM et al: Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax, 2005; 60: 293-300 (Pubitemid 40522365)
21. Hurst JR, Perera WR, Wilkinson TMA et al: Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2006; 173: 71-78 (Pubitemid 43069790)
22. Stevenson NJ, Walker PP, Costello RW, Calverley MPA: Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2005; 172: 1510-1516 (Pubitemid 43076538)
23. Tkacova R, Kluchova Z, Joppa P et al: Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med, 2007; 101: 1670-1676 (Pubitemid 46930714)
24. Perera WR, Hurst JR, Wilkinson TM et al: Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J, 2007; 29: 527-534
25. WHO - The World health report 2002, Reducing Risks, Promoting Healthy Life, 2002
26. Miller MR, Hankinson J, Brusasco V et al: Standardisation of spirometry. Eur Respir J, 2005; 26: 319-338
27. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med, 1976; 15: 212-216
28. Vibhuti A, Arif E, Deepak D et al: Correlation of oxidative stress status with BMI and lung function in COPD. Clinical Biochechemistry, 2007; 40: 958-963 (Pubitemid 47301791)
29. Mannino DM, Watt G, Hole D et al: The natural history of chronic obstructive pulmonary disease. Eur Respir J, 2006; 27: 627-643 (Pubitemid 43372539)
30. Takahashi T, Ichinose M, Inoue H et al: Underdiagnosis and undertreatment of COPD in primary care settings. Respirology, 2003; 8: 504-508 (Pubitemid 38009647)
31. Festa A, D'Agostino R Jr, Williams K et al: The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord, 2001; 25: 1407-1415 (Pubitemid 32977855)
32. Forouhi NG, Sattar N, McKeigue PM: Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord, 2001; 25: 1327-1331 (Pubitemid 32835450)
33. Sin DD, Man SF: Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 2003; 107: 1514-1519
34. Cirillo DJ, Agrawal Y, Cassano PA: Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey. Am J Epidemiol, 2002; 155: 842-848 (Pubitemid 34456995)
35. Pinto-Plata VM, Livnat G, Girish M et al: Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbations of COPD. Chest, 2007; 131: 37-43 (Pubitemid 46122972)
36. Perera WR, Hurst JR, Wilkinson TMA et al: Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J, 2007; 29: 527-534
37. Koutsokera A, Kiropoulos TS, Nikoulis DJ et al: Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med, 2009; 103: 919-926
38. Papaetis GS, Anastasakou E, Tselou T et al: Serological diagnosis of Chlamydophila pneumoniae infection in Greek COPD patients by microimmunofluorescence and ELISA. Med Sci Monit, 2008; 14(9): MT27-35
39. Noguera A, Malo O, Sauleda J et al: Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol, 2002; 38: 172-176
40. Lerario MC, Sachs A, Lazaretti-Castro M et al: Body composition in patients with chronic obstructive pulmonary disease: which method to use in clinical practice? Br J Nutr, 2006; 96: 86-92
41. Ridker PM, Glynn RJ, Hennekens CH: C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation, 1998; 97: 2007-2011
42. Yeh ET: High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol, 2005; 28: 408-412 (Pubitemid 41254302)
43. Pinto-Plata V, Toso J, Lee K et al: Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2006; 3: 465-466